000 01049 a2200277 4500
005 20250518043205.0
264 0 _c20200603
008 202006s 0 0 eng d
022 _a1522-9645
024 7 _a10.1093/eurheartj/ehz199
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMesserli, Franz H
245 0 0 _aCardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?
_h[electronic resource]
260 _bEuropean heart journal
_c06 2019
300 _a1787-1789 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aCardiovascular Diseases
650 0 4 _aDrug Labeling
650 0 4 _aFebuxostat
650 0 4 _aHumans
650 0 4 _aThiazoles
650 0 4 _aUric Acid
700 1 _aBurnier, Michel
773 0 _tEuropean heart journal
_gvol. 40
_gno. 22
_gp. 1787-1789
856 4 0 _uhttps://doi.org/10.1093/eurheartj/ehz199
_zAvailable from publisher's website
999 _c29772947
_d29772947